Anatomic extent of pelvic lymph node dissection: Impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy

Urology

Volumn 82, Issue 3, 2013, Pages 653-659

  Bivalacqua, Trinity J ^a   Pierorazio, Phillip M ^a   Gorin, Michael A ^a   Allaf, Mohamad E ^a   Carter, H Ballentine ^a   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER SPECIFIC SURVIVAL; EXTENDED PELVIS LYMPH NODE DISSECTION; FOLLOW UP; HUMAN; LIMITED PELVIS LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATECTOMY; SURGEON; SURGICAL APPROACH; TREATMENT DURATION;

ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 84883215403     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.03.086     Document Type: Article

References (30)

1. S.E. Eggener, P.T. Scardino, and P.C. Walsh Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 2011 869 875
2. J.B. Eifler, Z. Feng, and B.M. Lin An updated prostate cancer staging nomogram (partin tables) based on cases from 2006 to 2011 BJU Int 111 2013 22 29
3. S. Daneshmand, M.L. Quek, and J.P. Stein Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results J Urol 172 2004 2252 2255
4. S.A. Boorjian, R.H. Thompson, and S. Siddiqui Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era J Urol 178 2007 864 870
5. A. Briganti, J.R. Karnes, and L.F. Da Pozzo Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy Eur Urol 55 2009 261 270
6. A. Heidenreich, Z. Varga, and R. Von Knobloch Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis J Urol 167 2002 1681 1686
7. A. Briganti, F.K. Chun, and A. Salonia Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy Urology 69 2007 147 151
8. K. Touijer, F. Rabbani, and J.R. Otero Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% J Urol 178 2007 120 124
9. F. Abdollah, M. Sun, and R. Thuret Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer Int J Urol 19 2012 645 651
10. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 55 2009 1251 1265
11. G.S. Palapattu, E.A. Singer, and E.M. Messing Controversies surrounding lymph node dissection for prostate cancer Urol Clin North Am 37 2010 57 65
12. J.C. La Rochelle, and C.L. Amling Role of lymphadenectomy for prostate cancer: indications and controversies Urol Clin North Am 38 2011 387 395
13. J. Miki, and S. Egawa The role of lymph node dissection in the management of prostate cancer Int J Clin Oncol 16 2011 195 202
14. M.E. Allaf, G.S. Palapattu, and B.J. Trock Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer J Urol 172 2004 1840 1844
15. R. Schiavina, F. Manferrari, and M. Garofalo The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer BJU Int 108 2011 1262 1268
16. S.A. Joslyn, and B.R. Konety Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer Urology 68 2006 121 125
17. T.A. Masterson, F.J. Bianco Jr., and A.J. Vickers The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer J Urol 175 2006 1320 1324
18. M. Fujisawa, and H. Miyake Significance of micrometastases in prostate cancer Surg Oncol 17 2008 247 252
19. J.I. Epstein, G. Pizov, and P.C. Walsh Correlation of pathologic findings with progression after radical retropubic prostatectomy Cancer 71 1993 3582 3593
20. M.S. Cookson, G. Aus, and A.L. Burnett Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes J Urol 177 2007 540 545
21. D.S. DiMarco, H. Zincke, and T.J. Sebo The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era J Urol 173 2005 1121 1125
22. A.M. Murphy, D.S. Berkman, and M. Desai The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy BJU Int 105 2010 176 179
23. V. Pagliarulo, D. Hawes, and F.H. Brands Detection of occult lymph node metastases in locally advanced node-negative prostate cancer J Clin Oncol 24 2006 2735 2742
24. A.C. Ferrari, N.N. Stone, and R. Kurek Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment J Clin Oncol 24 2006 3081 3088
25. N.N. Stone, R.G. Stock, and P. Unger Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques J Urol 158 1997 1891 1894
26. T. Clark, D.J. Parekh, and M.S. Cookson Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer J Urol 169 2003 145 147
27. A. Briganti, F.K. Chun, and A. Salonia Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer Eur Urol 50 2006 1006 1013
28. M. Musch, V. Klevecka, and U. Roggenbuck Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006 J Urol 179 2008 923 928
29. B.H. Bochner, H.W. Herr, and V.E. Reuter Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens J Urol 166 2001 2295 2296
30. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597